larotrectinib January 19, 2018 larotrectinib Trade Name Orphan Indication Solid tumors with NTRK-fusion proteins USA Market Approval USA USA Designation Date 2017-05-09 00:00:00 Sponsor Loxo Oncology, Inc.;281 Tresser Boulevard, 9th Floor;Stamford, Connecticut, 06901
